Iris Lansdorp‐Vogelaar

18.6k total citations · 5 hit papers
249 papers, 11.7k citations indexed

About

Iris Lansdorp‐Vogelaar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Iris Lansdorp‐Vogelaar has authored 249 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Oncology, 136 papers in Pulmonary and Respiratory Medicine and 92 papers in Surgery. Recurrent topics in Iris Lansdorp‐Vogelaar's work include Colorectal Cancer Screening and Detection (215 papers), Gastric Cancer Management and Outcomes (135 papers) and Genetic factors in colorectal cancer (77 papers). Iris Lansdorp‐Vogelaar is often cited by papers focused on Colorectal Cancer Screening and Detection (215 papers), Gastric Cancer Management and Outcomes (135 papers) and Genetic factors in colorectal cancer (77 papers). Iris Lansdorp‐Vogelaar collaborates with scholars based in Netherlands, United States and Canada. Iris Lansdorp‐Vogelaar's co-authors include Ann G. Zauber, Marjolein van Ballegooijen, Amy B. Knudsen, Karen M. Kuntz, Sidney J. Winawer, Michael J. O’Brien, Weiji Shi, Melvin Schapiro, Jerome D. Waye and Joel F. Panish and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Iris Lansdorp‐Vogelaar

236 papers receiving 11.4k citations

Hit Papers

Colonoscopic Polypectomy and Long-Term Prevention of Colo... 2009 2026 2014 2020 2012 2009 2019 2016 2021 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
    2012 2.2k citations Ann G. Zauber, Iris Lansdorp‐Vogelaar et al. profile →
  2. Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
    2009 1.5k citations Ann G. Zauber, Ahmedin Jemal et al. profile →
  3. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
    2019 531 citations Fanny E. Vuik, Iris Lansdorp‐Vogelaar et al. Gut profile →
  4. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies
    2016 335 citations Amy B. Knudsen, Ann G. Zauber et al. profile →
  5. Colorectal Cancer Screening
    2021 186 citations Amy B. Knudsen, Carolyn M. Rutter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Lansdorp‐Vogelaar Netherlands 49 9.8k 5.9k 3.5k 2.9k 752 249 11.7k
Wendy Atkin United Kingdom 51 9.3k 1.0× 4.9k 0.8× 3.7k 1.0× 2.6k 0.9× 605 0.8× 155 11.4k
Monique E. van Leerdam Netherlands 52 6.5k 0.7× 3.7k 0.6× 3.5k 1.0× 3.1k 1.1× 958 1.3× 331 9.5k
Durado Brooks United States 27 9.1k 0.9× 5.2k 0.9× 3.1k 0.9× 1.8k 0.6× 1.1k 1.4× 45 12.3k
Douglas A. Corley United States 63 6.4k 0.7× 6.2k 1.1× 1.7k 0.5× 7.4k 2.5× 1.3k 1.7× 272 14.8k
Marjolein van Ballegooijen Netherlands 55 9.9k 1.0× 5.3k 0.9× 3.1k 0.9× 3.6k 1.2× 3.8k 5.1× 197 13.5k
Michel Seymour United Kingdom 44 9.1k 0.9× 3.6k 0.6× 2.8k 0.8× 3.1k 1.1× 321 0.4× 239 12.5k
Michael Bretthauer Norway 48 5.6k 0.6× 4.0k 0.7× 1.5k 0.4× 2.4k 0.8× 416 0.6× 214 8.0k
Jean Faivre France 59 7.6k 0.8× 3.8k 0.6× 3.1k 0.9× 3.9k 1.3× 2.1k 2.8× 353 13.3k
Robert E. Schoen United States 55 6.6k 0.7× 3.9k 0.7× 2.8k 0.8× 2.0k 0.7× 861 1.1× 234 10.7k
Charles D. Blanke United States 57 8.5k 0.9× 9.6k 1.6× 2.1k 0.6× 5.8k 2.0× 1.1k 1.5× 292 18.5k

Countries citing papers authored by Iris Lansdorp‐Vogelaar

Since Specialization
Citations

This map shows the geographic impact of Iris Lansdorp‐Vogelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Lansdorp‐Vogelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Lansdorp‐Vogelaar more than expected).

Fields of papers citing papers by Iris Lansdorp‐Vogelaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Lansdorp‐Vogelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Lansdorp‐Vogelaar. The network helps show where Iris Lansdorp‐Vogelaar may publish in the future.

Co-authorship network of co-authors of Iris Lansdorp‐Vogelaar

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Lansdorp‐Vogelaar. A scholar is included among the top collaborators of Iris Lansdorp‐Vogelaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Lansdorp‐Vogelaar. Iris Lansdorp‐Vogelaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Mahony, James F., Dianqin Sun, Robert J. Huang, et al.. (2025). The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States. Helicobacter. 30(3). e70039–e70039. 2 indexed citations
2.
Jonge, Lucie de, et al.. (2025). Cost-effectiveness of colon capsule endoscopy in colorectal cancer screening: a modeling study. Endoscopy. 57(10). 1095–1105.
3.
Bulliard, Jean‐Luc, Aziz Chaouch, Marie‐Anne Durand, et al.. (2025). Colorectal Cancer Screening Based on Predicted Risk: A Randomized Controlled Trial. The American Journal of Gastroenterology. 120(10). 2432–2439. 1 indexed citations
4.
Seguin, Claudia L., Amy B. Knudsen, Pedro Nascimento de Lima, et al.. (2024). Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models. Medical Decision Making. 44(5). 543–553. 5 indexed citations
5.
Lima, Pedro Nascimento de, Amy B. Knudsen, Karen M. Kuntz, et al.. (2024). Characteristics of a cost-effective blood test for colorectal cancer screening. JNCI Journal of the National Cancer Institute. 116(10). 1612–1620. 10 indexed citations
6.
Huang, Robert J., Margaret Zhou, John D. Murphy, et al.. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 22(8). 1605–1617.e46. 18 indexed citations
7.
Siebers, Albert G., Birgit I. Lissenberg‐Witte, Iris Lansdorp‐Vogelaar, et al.. (2024). Risk factors for advanced colorectal neoplasia and colorectal cancer detected at surveillance: a nationwide study in the modern era. Histopathology. 85(4). 627–638. 1 indexed citations
8.
O’Mahony, James F., et al.. (2024). The Ethics of Cancer Screening Based on Race and Ethnicity. Annals of Internal Medicine. 177(9). 1259–1264. 6 indexed citations
9.
Meester, Reinier G.S., et al.. (2023). Development and validation of colorectal cancer risk prediction tools: A comparison of models. International Journal of Medical Informatics. 178. 105194–105194. 7 indexed citations
10.
Jonge, Lucie de, Esther Toes‐Zoutendijk, Manon C.W. Spaander, et al.. (2023). Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening. Clinical Gastroenterology and Hepatology. 21(13). 3424–3432.e2.
11.
McFerran, Ethna, James F. O’Mahony, Steffie K. Naber, et al.. (2022). Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?. MDM Policy & Practice. 7(1). 97843816–97843816. 6 indexed citations
12.
Gini, Andrea, Manon C.W. Spaander, Leon M.G. Moons, et al.. (2022). Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy. Cancer Epidemiology Biomarkers & Prevention. 31(12). 2157–2168. 3 indexed citations
13.
Lansdorp‐Vogelaar, Iris, et al.. (2022). Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis. Cancer Epidemiology Biomarkers & Prevention. 32(1). 22–29. 16 indexed citations
14.
Toes‐Zoutendijk, Esther, Geraldine R. Vink, Irıs D. Nagtegaal, et al.. (2021). Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands. European Journal of Cancer. 161. 38–43. 36 indexed citations
15.
Peterse, Elisabeth F.P., Reinier G.S. Meester, Lucie de Jonge, et al.. (2020). Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests. JNCI Journal of the National Cancer Institute. 113(2). 154–161. 65 indexed citations
16.
Meulen, Miriam P. van der, Monique E. van Leerdam, Ernst J. Kuipers, et al.. (2017). Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis. Cancer Epidemiology Biomarkers & Prevention. 26(8). 1328–1336. 17 indexed citations
17.
Haug, Ulrike, Esmée J. Grobbee, Iris Lansdorp‐Vogelaar, Manon C.W. Spaander, & Ernst J. Kuipers. (2016). Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?. Gut. 66(7). 1262–1267. 15 indexed citations
18.
Kong, Chung Yin, Sonja Kroep, Kit Curtius, et al.. (2014). Exploring the Recent Trend in Esophageal Adenocarcinoma Incidence and Mortality Using Comparative Simulation Modeling. Cancer Epidemiology Biomarkers & Prevention. 23(6). 997–1006. 50 indexed citations
19.
Lansdorp‐Vogelaar, Iris, Karen M. Kuntz, Amy B. Knudsen, et al.. (2012). Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiology Biomarkers & Prevention. 21(5). 728–736. 167 indexed citations
20.
Naishadham, Deepa, Iris Lansdorp‐Vogelaar, Rebecca L. Siegel, Vilma Cokkinides, & Ahmedin Jemal. (2011). State Disparities in Colorectal Cancer Mortality Patterns in the United States. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1296–1302. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Atkin Breakdown of academic impact, for papers by Monique E. van Leerdam Breakdown of academic impact, for papers by Durado Brooks Breakdown of academic impact, for papers by Douglas A. Corley Breakdown of academic impact, for papers by Marjolein van Ballegooijen Breakdown of academic impact, for papers by Michel Seymour Breakdown of academic impact, for papers by Michael Bretthauer Breakdown of academic impact, for papers by Jean Faivre Breakdown of academic impact, for papers by Robert E. Schoen Breakdown of academic impact, for papers by Charles D. Blanke
Rankless by CCL
2026